Browsing by Author Tabernero, Josep

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialClarke, Stephen; Cartwright, Thomas; Cunningham, David; De Gramont, A.; et al, Various; Hecht, J; Im, Seock-Ah; Moore, Malcolm; Rivera, Fernando; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, E; Concord Clinical School: MedicineBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial, Lancet Oncology, vol.13, 12, 2012,pp 1225-1233
2016Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trialClarke, Stephen; Cunningham, David; et al, Various; Kim, Sunyoung; Kim, Tae; Kim, Taeyou; Park, Youngsuk; Roh, Jae; Schmoll, Hans-Joachim; Sclafani, Francesco; Tabernero, Josep; Northern Clinical School: Kolling InstituteDalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial, International Journal of Cancer, vol.140, 2, 2016,pp 431-439
2016Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trialClarke, Stephen; Cunningham, David; et al, Various; Kim, Sunyoung; Kim, Tae; Kim, Taeyou; Park, Youngsuk; Roh, Jae; Schmoll, Hans-Joachim; Sclafani, Francesco; Tabernero, Josep; Northern Clinical School: Kolling InstituteDalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial, International Journal of Cancer, vol.140, 2, 2016,pp 431-439
2013Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factorsClarke, Stephen; Pavlakis, Nick; Desai, Jayesh; Gibbs, Peter; Karapetis, Christos; Michael, Michael; Pricek, T.J.; Tabernero, Josep; Tebbutt, Niall C; Concord Clinical School: Medicine; Northern Clinical School: MedicineOverview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors, Critical Reviews in Oncology / Hematology (online), vol.85, 2, 2013,pp 121-135